Products of Roche Products Limited.

Rocephin 1G Powder for injection I.M# Powder for injection
Ceftriaxone
1 g
NRN: 04-7302
Rocephin Powder for Injection 1G# Powder for injection
Ceftriaxone
1 g
NRN: 04-73022023-01-23
Actemra 162mg Injection
Tocilizumab
162 mg
NRN: A6-100070
Actemra 200mg Injection
Tocilizumab
200 mg
NRN: A6-100067
Actemra 400mg Injection
Tocilizumab
400 mg
NRN: A6-100066
Kadcyla 160mg vial# Powder for concentrate for solution for infusion
Trastuzumab emtansine
160 mg
NRN: A6-100105
Kadcyla 100mg Powder# Powder for concentrate for solution for infusion
Trastuzumab emtansine
100 mg
NRN: A6-0506
MABTHERA 1400MG SOLUTION FOR SUBCUTANEOUS INJECTION# Solution for injection
Rituximab
1400 mg/11.7 mL
NRN: A6-0505
Ocrevus# Intravenous infusion
Ocrelizumab
300mg/vial
NRN: A6-100051
Vabysmo# Solution for injection (Inravitreal)
Faricimab
6 mg/0.05 mL (120 mg/mL)
NRN: A6-100124
Actemra 80mg Injection
Tocilizumab
80 mg
NRN: A6-100068
Avastin 100 mg** Concentrate for solution for infusion
Bevacizumab
100 mg/4 mL
NRN: A6-0123
Enspryng* Solution for injection
Satralizumab
120 mg/mL
NRN: A6-100128
Hemlibra 150mg* Solution for injection
Emicizumab
150 mg/mL
NRN: A6-100134
Hemlibra 30mg* Solution for injection
Emicizumab
30 mg/mL
NRN: A6-100132
Phesgo 600mg/600mg/10ml# Injection
Pertuzumab; Trastuzumab
600mg/10ml; 600mg/10ml
NRN: A6-100047
Hemlibra 60mg* Solution for injection
Emicizumab
60 mg/ 0.4mL
NRN: A6-100133
Enspryng Satralizumab* Injection
Satralizumab
120 mg
NRN: A6-100128
Mircera 50mcg# Injection
Methoxy polyethylene glycol-epoetin beta
50 mcg/0.3 mL
NRN: A6-0121
Mircera 75mcg# Injection
Methoxy polyethylene glycol-epoetin beta
75 mcg/0.3 mL
NRN: A6-0106
VABYSMO# Injection
Faricimab
6 mg
NRN: A6-100124
Phesgo 1200mg/600mg/15ml# Injection
Pertuzumab; Trastuzumab
1200mg/15ml; 600mg/15ml
NRN: A6-100063
Herceptin Solution for Injection (for Subcutaneous Use)** Solution for injection
Trastuzumab hyaluronidase (SC formulation)
600 mg/5 mL
NRN: A6-0481